Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Comparison of a Currently Marketed Hearing Aid Programmed With Two Different Fitting Methods

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03498274
Recruitment Status : Terminated (Insufficient recruitmen)
First Posted : April 13, 2018
Last Update Posted : January 23, 2019
Sponsor:
Information provided by (Responsible Party):
Bernafon AG

Brief Summary:
This study is designed to investigate the benefits of the hearing aid in the laboratory and in daily life when fitted with two different methods. Subjective and objective evaluations will be made. The aim is to show the benefits of the hearing aids with both fitting methods with the help of data obtained, and to improve the available fitting methods in order to further increase the benefit for people with hearing disorders in situations where the standard method and those trained to perform it are not available.

Condition or disease Intervention/treatment Phase
Hearing Loss Device: Fitting System Device: Traditional Fitting System Not Applicable

Detailed Description:

Benefits of amplification and accessories used with it outweigh anticipated risks in mild to profound hearing impaired subjects. The basic benefit of amplification should be present with any method that the trained professional fitting the instruments uses. The goal of this study is to compare two fitting methods and determine whether the end user perceives more benefit from one fitting method over the other. The objective benefit is expected to be the same; however, the subjective benefit may be different due to a possible psychological effect from more effort or time spent by the trained professional.

Bernafon will conduct this clinical investigation to test current hearing instruments fitted with the standard procedure and a self-directed procedure. Safety and performance validation of the new self-directed fitting software is needed before release to the market.

The reason for this study is to evaluate a currently marketed, CE certified, hearing aid and determine whether different fitting methods provide the same perceived benefit. Additionally, this study will validate the safety of the fitting procedure as well as collect post market safety information about the devices themselves. The goal is to evaluate the audiological performance objectively as well as the subjective benefit. Furthermore, it is important to identify unexpected, unwanted behavior from the fitting software and the devices.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 14 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Intervention Model Description: This is a controlled, randomized, cross-over, open label, comparative clinical investigation. A randomized cross-over design is used with half of the test subjects wearing the device fit with the traditional fitting method first and the other half using the self-directed method and then switching after approximately 10 +/-5 days.
Masking: None (Open Label)
Primary Purpose: Other
Official Title: A Comparative, Controlled, Clinical Investigation of a Currently Marketed Hearing Aid When Programmed With Two Different Fitting Methods
Actual Study Start Date : March 19, 2018
Actual Primary Completion Date : June 11, 2018
Actual Study Completion Date : June 11, 2018

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Fitting System
a self-directed hearing screening based on a known algorithm from Audiology Inc. sold in an automated audiogram by Grason Stadler, GSI and a simplified version of the software. The flow of the new software is driven by the end user, but a trained professional should always assist with the fitting. The new software will first perform a hearing screening on the end user and then recommend a hearing aid and prescribe amplification to the hearing aid based on the hearing screening results.
Device: Fitting System
End users will drive the screening and fitting flow; however, a trained professional is intended to assist them and help with explanations and the actual fitting of the hearing aids on the person. For a first time user the physical act of placing the hearing aid in/on the ear may create confusion. Therefore, the software is designed for an assistant to guide the user through the process and help with specific parts of the fitting or any questions in general.

Active Comparator: Traditional Fitting System
A traditional fitting method will be used as a control. This system is controlled by a trained professional, who performs the entire fitting without much interaction from the end user. The hearing instruments will be fit with the same settings as the experimental arm.
Device: Traditional Fitting System
The trained professional will fit the hearing aids with the traditional software that is currently used on the market. They will not involve the patient except to play demonstration tones.




Primary Outcome Measures :
  1. Assessment of subjective benefit with the standardized questionnaire, International Outcome Inventory For Hearing Aids (IOI-HA) [ Time Frame: Time frame to assess change is one month with the first measure after two weeks and the second week 3-4 ]
    The answers to the questionnaire will be compared for each fitting method to determine if the subjective hearing aid benefit is as good when using the IMD as with the RMD. There is no numerical outcome.


Secondary Outcome Measures :
  1. Assessment of speech understanding with a standardized speech test that uses the percentage of words correct to score the performance. [ Time Frame: Time frame to assess change is one month with the first measure after two weeks and the second week 3-4 ]
    A standardized speech test will be given after each field test to compare the two fitting methods. Percentage of correct words repeated from both fitting methods will be compared to determine whether one method helped the subjects to achieve higher speech scores.

  2. Assessment of hearing aid preference with a questionnaire [ Time Frame: Time frame to assess change is one month after the hearing aids have been worn with both fitting methods. ]
    To assess if the subjects prefer one hearing aid over the other they will complete a preference questionnaire that asks specifically which hearing aid they preferred and why. There is no point scale just a selection of Hearing aid 1 or hearing aid 2.


Other Outcome Measures:
  1. Assessment of unexpected device behavior (ie. distortion) with a questionnaire [ Time Frame: Time frame to assess change is one month with the first measure after two weeks and the second week 3-4 ]
    To assess the system for any unexpected behaviors and to evaluate any new risk factors to ensure safety of the devices, a questionnaire that distinctly asks questions about the occurence of unexpected noises such as excessive feedback or distortion will be given to the subjects. The questionnaire is based on a 5-point scale to quantify the rate of occurrence (with 1 being never to 5 being often).



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • All types of hearing loss (sensorineural, conductive, mixed)
  • If the hearing loss is conductive or mixed it must first be approved for amplification by a physician
  • All shapes of hearing loss (flat, sloping, reverse slope, notch)
  • Severity ranging from mild to severe
  • First time hearing aid users (never worn hearing aids before)
  • German speaking
  • Both genders
  • Ages 18 and older
  • Ability and willingness to sign the consent form

Exclusion Criteria:

  • Current hearing aids users
  • Contraindications for amplification
  • Active ear disease
  • Inability to follow the procedures of the study due to language problems, psychological disorders, dementia, or other cognitive problems of the participant
  • A reduced mobility unable to attend weekly study appointments
  • A reduced ability to describe auditory impressions and the usage of the hearing aids
  • Uncooperative so that it is not possible to record a valid pure tone audiogram
  • A strongly reduced dexterity
  • With psychological problems
  • Central hearing disorders
  • Bernafon employees
  • Family members of Bernafon employees

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03498274


Locations
Layout table for location information
Switzerland
Audika
Thun, Bern, Switzerland, 3600
Audika
Bern, Switzerland, 3011
Sponsors and Collaborators
Bernafon AG
Investigators
Layout table for investigator information
Principal Investigator: Barbara Simon Employee
  Study Documents (Full-Text)

Documents provided by Bernafon AG:
Statistical Analysis Plan  [PDF] December 21, 2017
Study Protocol  [PDF] December 21, 2017


Publications:
Layout table for additonal information
Responsible Party: Bernafon AG
ClinicalTrials.gov Identifier: NCT03498274    
Other Study ID Numbers: BF002-1707
First Posted: April 13, 2018    Key Record Dates
Last Update Posted: January 23, 2019
Last Verified: January 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Product Manufactured in and Exported from the U.S.: No
Keywords provided by Bernafon AG:
Fitting
Additional relevant MeSH terms:
Layout table for MeSH terms
Hearing Loss
Seizures
Hearing Disorders
Ear Diseases
Otorhinolaryngologic Diseases
Sensation Disorders
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms